Retatrutide, from Soma, represents a promising soma chems retatrutide advance in weight regulation. This unique drug combines incretin receptor agonist properties with gut-derived receptor engagement, showing substantial results in clinical data for metabolic loss . Scientists believe this treatment could offer a alternative option for individuals